Cowen And Company, LLC Clovis Oncology, Inc. Put Options Transaction History

Cowen And Company, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	SELL	$2.7 - $4.76 $194,940 - $343,672	-72,200 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$4.06 - $5.8 $271,208 - $387,440	66,800 Added 1237.04%	72,200 $27,000
Q2 2021 Aug 13, 2021	BUY	$5.02 - $7.05 $27,107 - $38,070	5,400 New	5,400 $1,000
Q2 2020 Aug 13, 2020	SELL	$5.69 - $9.69 $911,538 - $1.55 Million	-160,200 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$3.77 - $11.0 $603,954 - $1.76 Million	160,200 New	160,200 $229,000
Q4 2019 Feb 11, 2020	SELL	$3.0 - $16.43 $45,000 - $246,450	-15,000 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$3.93 - $15.35 $58,950 - $230,250	15,000 New	15,000 $107,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.